Tag Archives: teva

Mylan Rejects Teva Bid After Raising Bid For Perrigo

Mylan (MYL) rejected a takeover bid from Teva Pharmaceutical (TEVA) on Monday but said it was still was committed to its offer for Perrigo (PRGO). The generic pharmaceutical company said the $40 billion offer undervalued the company and “would require Mylan’s shareholders to accept what we believe are low-quality Teva shares in exchange for their high-quality Mylan shares.” Many analysts believe Teva could and would offer more. But Mylan’s fierce

Teva Bids $40 Billion For Mylan, But May Need More

Israeli drug giant Teva Pharmaceutical Industries (TEVA) made its long-awaited bid for competitor Mylan on Tuesday, offering $82 a share, or $40.1 billion. Both stocks rose on the news. Teva’s proposal, half cash and half stock, was unsolicited by Mylan (MYL), which adopted a poison-pill provision this month after initial reports of Teva’s interest emerged. On April 8, Mylan made its own unsolicited bid for fellow generic-drug maker Perrigo (PRGO)

Teva Offers $82 A Share For Mylan; Stocks Rise

Teva Pharmaceutical Industries (TEVA) made a long-rumored bid for smaller generics rival Mylan (MYL) on Tuesday — 82 a share. Both stocks rose in pre-market trading. But over-the-counter products maker Perrigo (PRGO), which has an offer from Mylan, fell in early trading. Israeli-based Teva offered to buy Mylan for $40.1 billion, or 82 a share, in equal parts cash and stock. “The proposed combination of Teva and Mylan would create a leading company